Viewing Study NCT00006269


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-28 @ 7:34 PM
Study NCT ID: NCT00006269
Status: TERMINATED
Last Update Posted: 2012-05-25
First Post: 2000-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module